Most people pay far too much for a GLP-1 because they never line up the four savings tools that exist: manufacturer copay cards, manufacturer self-pay programs, third-party discount cards, and patient assistance programs. Each one fits a different situation, and the rules about combining them trip up almost everyone. This guide lays out every program in 2026, what you actually qualify for, and the stacking rules that decide your real out-of-pocket cost.
For the bigger picture, see the GLP-1 price comparison, the cheapest GLP-1 paths ranked, and the insurance coverage guide.
Direct answer: If you have commercial insurance that covers the drug, the manufacturer copay card is the winner — $0–$25/month, capped around $100–$150 per fill. If you have no coverage, skip the card (it requires commercial insurance) and use manufacturer self-pay: NovoCare sells Wegovy/Ozempic at $349/month ($199 intro) and the Wegovy pill from $149; LillyDirect sells Zepbound vials at $299–$449. GoodRx is the fallback at any pharmacy but cannot be combined with a copay card. Patient assistance programs give the drug free to low-income, uninsured patients. Government beneficiaries (Medicare/Medicaid) are excluded from both copay cards and self-pay programs.
The four savings tools at a glance
| Tool | Who it is for | Typical cost | Key limit |
|---|---|---|---|
| Manufacturer copay card | Commercially insured, drug covered | $0–$25/mo | Excludes Medicare/Medicaid; annual cap |
| Manufacturer self-pay program | Uninsured or drug not covered | $149–$449/mo | Cash only; no government plans |
| Third-party discount card (GoodRx, SingleCare) | Anyone, especially uninsured | $199–$349/mo | Cannot stack with a copay card |
| Patient assistance program (PAP) | Uninsured, low income | $0 | Strict income documentation |
Manufacturer copay cards (the best deal with insurance)
A copay card lowers what you pay at the counter when your commercial plan already covers the drug. It does nothing on its own — it sits on top of insurance.
- Wegovy Savings Card (Novo Nordisk): as little as $0–$25/month for commercially insured patients whose plan covers Wegovy, with a maximum savings cap around $225 per 28-day supply. If your plan does not cover Wegovy, a separate offer brings it to about $499/month, but that loses to self-pay.
- Ozempic Savings Card (Novo Nordisk): as little as $25 per prescription for covered patients, with a per-fill maximum savings cap (around $150).
- Zepbound Savings Card (Eli Lilly): $0–$25/month for covered commercial patients; a separate non-covered offer aligns with LillyDirect self-pay vial pricing.
- Mounjaro Savings Card (Eli Lilly): as little as $25/month for commercially insured type 2 diabetes patients, with a monthly and annual cap.
The universal catch: copay cards exclude anyone with Medicare, Medicaid, or other government insurance. That exclusion is federal law, not a manufacturer choice. If you are on Medicare, look to the GLP-1 Bridge demonstration starting July 2026 instead.
Manufacturer self-pay programs (best without insurance)
When insurance does not cover the drug — or you have none — the manufacturers sell directly at far below retail:
- NovoCare Pharmacy (Wegovy, Ozempic): Wegovy injection $199/month for the first two fills, then $349; Wegovy pill from $149; Ozempic on the same $199 intro/$349 structure. Ships to home, fulfilled by CenterWell.
- LillyDirect Self Pay (Zepbound): vials at $299 (2.5 mg), $399 (5 mg), and $449 for higher doses under the Self Pay Journey Program — provided you refill within 45 days. Available by direct ship or pickup at any Walmart pharmacy.
These are cash programs and, like copay cards, exclude government beneficiaries. They are detailed channel-by-channel in the pharmacy pricing map.
Third-party discount cards
GoodRx, SingleCare, and similar cards negotiate cash prices at retail pharmacies. GoodRx now runs GLP-1-specific pricing: $199/month introductory for the first two Ozempic or Wegovy fills, then $299–$349, with an optional $39/month telehealth visit. The Wegovy pill runs under $150. Discount cards are the most flexible option — they work for almost anyone at almost any pharmacy — but they cannot be combined with a manufacturer copay card. You choose one.
Patient assistance programs (free drug)
Both manufacturers run patient assistance programs (PAPs) that provide the medication at no cost to patients who are uninsured and below an income threshold (commonly around 400% of the federal poverty level). These require an application, proof of income, and usually a prescriber''s sign-off, and they are not advertised prominently — but for qualifying patients they are the cheapest option that exists. Start at the manufacturer''s patient-assistance page (NovoCare and Lilly Cares).
The stacking rules everyone gets wrong
- Copay card + insurance: yes — this is the intended combination and the cheapest legitimate path.
- Copay card + GoodRx/discount card: no — you cannot use both on the same fill. Pick whichever is lower (the copay card wins when insurance covers the drug).
- Copay card + Medicare/Medicaid: prohibited by law.
- Self-pay program + insurance: no — self-pay means you are not running it through insurance at all.
- GoodRx + Medicare: allowed, because GoodRx is a cash discount, not insurance — but you cannot apply it to a drug you are also billing to Medicare.
How to choose in 60 seconds
- Commercial insurance that covers the drug? Use the manufacturer copay card. Done — $0–$25/month.
- Commercial insurance that excludes the drug, or no insurance? Compare manufacturer self-pay (NovoCare/LillyDirect) against GoodRx for your exact drug and dose.
- Uninsured and low income? Apply to the patient assistance program for $0 drug.
- On Medicare or Medicaid? Copay cards and self-pay are off-limits; rely on Part D coverage and the July 2026 Bridge.
What people get wrong
- "The savings card works no matter what." It requires commercial insurance and excludes government plans. Uninsured patients need self-pay or a PAP instead.
- "I can stack GoodRx on top of my copay card." You cannot. One discount per fill.
- "Self-pay is the same as using my insurance." No — self-pay programs bypass insurance entirely, which is why they exclude Medicare/Medicaid.
- "There''s no help if my plan excludes the drug." There is: manufacturer non-covered offers, self-pay programs, GoodRx, and PAPs all exist for exactly this case.
Frequently asked questions
What is the cheapest way to pay for a GLP-1? Commercial insurance plus a manufacturer copay card: $0–$25/month. Without insurance, manufacturer self-pay (from $149 for orals, $299–$349 for injectables) or a patient assistance program if you qualify.
Can I use a manufacturer savings card with Medicare? No. Federal anti-kickback rules exclude Medicare, Medicaid, and other government beneficiaries from manufacturer copay cards.
Can I combine GoodRx with a copay card? No. You can use only one discount per prescription fill. Compare them and choose the lower price — usually the copay card when insurance covers the drug.
My insurance does not cover Wegovy. What now? Use NovoCare self-pay (from $149 for the pill, $349 for injection), compare against GoodRx, and check whether you qualify for a patient assistance program. See the cheapest GLP-1 guide.
Do these programs work for compounded GLP-1? No. Manufacturer cards and self-pay programs apply only to branded products. Compounded drugs are priced separately by the compounding pharmacy or telehealth provider.
Last reviewed: May 28, 2026
